Chester County News and Community Website
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced that the Company will host a virtual Key Opinion Leader event on radiotherapy-induced severe oral mucositis (SOM) in patients with head …
Read More
MALVERN, PA — Representative Chrissy Houlahan (D-PA) on Wednesday joined Novocure leadership to tour their Malvern facility and learn more about their vital work. There, she heard about their mission …
Read More
PLYMOUTH MEETING, PA — Among all patients with neuroendocrine tumors (NETs), the risk of dying of cancer was higher than that of dying of other causes, but mortality varies by primary …
Read More
CHEYNEY, PA — Navrogen Inc. and Tavotek Biotherapeutics announced today that they have entered into a strategic collaboration to identify and develop experimental monoclonal antibodies (mAbs) for the treatment of …
Read More
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network (NCCN®) this week announced the publication of new NCCN Guidelines for Patients® Anal Cancer, in addition to recently updated patient guidelines for colon and rectal cancers.
Read More
WASHINGTON, D.C. — The following quote is attributed to Richard Pazdur, M.D., director of the FDA’s Oncology Center of Excellence and acting director of the Office of Oncologic Diseases in …
Read More
MALVERN PA — HMP Global, a leading healthcare event and education company, announced the agenda and faculty lineup for its inaugural Great Debates & Updates in Women’s Oncology, taking place …
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Cosela (trilaciclib) as the first therapy in its class to reduce the frequency of chemotherapy-induced bone marrow suppression in adults …
Read More
MALVERN, PA — As part of its continued mission to connect the global healthcare community with clinically relevant information and education that improves patient care, HMP Global, a leading healthcare …
Read More MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy …
Read More